"Levine Cancer Institute University City, a facility of Carolinas Medical Center, conveniently located in Charlotte, NC, offers physician consultation, laboratory, and chemotherapy appointments in state of the art facilities."

During the past decade, Levine Cancer Institute-University conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Levine Cancer Institute-University" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator and "Medivation, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Levine Cancer Institute-University" are "Prostate Cancer" (2 trials), "Borderline Resectable Adenocarcinoma of the Head of the Pancrease" (1 trials), "Breast Cancer" (1 trials), "Pancreatic Adenocarcinoma" (1 trials) and "Pancreatic Cancer" (1 trials). Many other conditions were trialed in "Levine Cancer Institute-University" in a lesser frequency.

Most popular intervention types in "Levine Cancer Institute-University" are "Drug" (4 trials), "Radiation" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Enzalutamide" (1 trials), "FOLFOX" (1 trials), "Placebo" (1 trials), "Talazoparib" (1 trials) and "WBI" (1 trials). Other intervention names were less common.

The vast majority of trials in "Levine Cancer Institute-University" are 2 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Levine Cancer Institute-University". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Levine Cancer Institute-University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Levine Cancer Institute-University, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".